$TNYA
Tenaya Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · South San Francisco, CA
TNYA chart
What traders are saying about $TNYA
Latest postsTenaya Therapeutics, Inc. news
- Tenaya Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Weekly Recap: Q3 results and cash runway and TN-401 FDA RMAT designation
TradingView ·
- TNYA News | TENAYA THERAPEUTICS INC (NASDAQ:TNYA)
ChartMill ·
- Tenaya Therapeutics, Inc. expected to post a loss of 10 cents a share - Earnings Preview
TradingView ·
- Tenaya Therapeutics earnings beat by $0.02, revenue topped estimates
Investing.com ·
- Tenaya Therapeutics, Inc. (TNYA) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Tenaya Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Tenaya Therapeutics reports Q3 2026 results, FD...
Pluang ·
- Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
Yahoo Finance ·
- Treasury yields rise as investors raise bets on Fed rate hike: AlphaCheck
Yahoo Finance ·
- Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
Yahoo Finance ·
Tenaya Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$90.6M | -$111.1M | -$124.1M | -$123.7M |
| Diluted EPS | $-0.59 | $-1.31 | $-1.68 | $-2.76 |
| Total assets (year end) | $146.9M | $119.9M | $170.5M | $278.9M |
| Cash and equivalents (year end) | $100.5M | $4.3M | $45.7M | $95.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tenaya Therapeutics, Inc.
- Ticker
- TNYA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1858848
Frequently asked questions
What exchange is Tenaya Therapeutics, Inc. listed on?
Tenaya Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TNYA.
What industry is Tenaya Therapeutics, Inc. in?
Tenaya Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Tenaya Therapeutics, Inc. headquartered?
Tenaya Therapeutics, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Tenaya Therapeutics, Inc.'s fiscal year end?
Tenaya Therapeutics, Inc.'s fiscal year ends on December 31.